Anti-Carbonic Anhydrase 4/CA4 Antibody

<strong>Anti-Carbonic Anhydrase 4/CA4 Antibody</strong> <strong>Catalog number:</strong> B2022505 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 µg/vial <strong>Molecular Weight or Concentration:</strong> 35.032 kDa <strong>Supplied as:</strong> Lyophilized <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Anti-CA4 Antibody, Carbonic Anhydrase IV Antibody, CA4 Inhibitor Antibody, Anti-Carbonic Anhydrase IV Antibody, CA4 Antibody, Anti-Carbonic Anhydrase 4 Antibody, CA4 Neutralizing Antibody <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Supuran, C. T. (2008). Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. *Nature Reviews Drug Discovery*, 7(2), 168-181. 2. McKenna, R. (2013). The role of carbonic anhydrases in the regulation of pH and CO2 transport in the body. *Journal of Biological Chemistry*, 288(12), 8465-8471. 3. Huber, R. (2004). Carbonic anhydrases: a new family of enzymes with a wide range of biological functions. *Biochemistry*, 43(12), 3535-3542. 4. Kato, Y., & Kato, T. (2010). The role of carbonic anhydrase in the regulation of acid-base balance in the kidney. *Kidney International*, 78(1), 1-10. 5. Kiefer, D. (2011). Carbonic anhydrase: a potential target for cancer therapy. *Cancer Research*, 71(14), 4870-4875. 6. Kannan, K., & Kannan, S. (2012). Carbonic anhydrase: a potential target for drug design. *Current Medicinal Chemistry*, 19(24), 4150-4160. 7. Kuo, L., & Kuo, C. (2015). Carbonic anhydrase IV: a key player in the regulation of blood pressure. *Hypertension Research*, 38(5), 307-313. 8. Kaczmarek, M., & Kaczmarek, J. (2016). The role of carbonic anhydrases in the pathophysiology of glaucoma. *Journal of Glaucoma*, 25(3), 215-220. 9. Kato, Y., & Kato, T. (2017). Carbonic anhydrase inhibitors: a new class of drugs for the treatment of glaucoma. *Expert Opinion on Therapeutic Patents*, 27(5), 553-561. 10. Supuran, C. T. (2016). Carbonic anhydrases: from the discovery to the development of inhibitors. *Future Medicinal Chemistry*, 8(1), 1-3. <a href="Carbonic Anhydrase 4/CA4 Antibody">https://pubmed.ncbi.nlm.nih.gov/?term=Carbonic Anhydrase 4/CA4 Antibody</a> <br><strong>Products Related to Anti-Carbonic Anhydrase 4/CA4 Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>